focuses on degeneration
and regeneration of
musculoskeletal tissues,
particularly intervertebral
disc, articular cartilage and
tendonous tissues. Her lab
uses tools of bioengineering,
cellular and molecular biology
and animal physiology to
develop new treatment
strategies for repairing
arthritic and diseased
musculoskeletal tissues.
Chavan's research is in
bioelectronic medicine,
and developing knowledge
about the neuroanatomical
pathways and neural codes in
the vagus nerve that underlie
its regulation of the immune
response. She also works to
develop targeted therapeutics
for the treatment of long-
term effects of inflammatory
diseases.
is on the early identification
and treatment of adolescents
and young adults who are
considered to be at-risk for
developing serious psychiatric
illness as adults, especially
schizophrenia and other
psychotic disorders. She
directs the Recognition and
Prevention (RAP) program.
activation and maturation
of B-lymphocytes, and uses
this information to develop
and test new diagnostics
and treatments for patients
suffering from chronic
lymphocytic leukemia (CLL), a
B-lymphocyte cancer residing
in the blood, bone marrow
and lymphoid tissues. His
studies have impacted CLL
patient prognosis and care.
identification and treatment
of patients with severe
psychiatric disorders. His
areas of focus include
schizophrenia-spectrum,
mood-spectrum and
aggressive-spectrum
disorders. He is also an expert
in the risk-benefit evaluation
of psychotropic medications.
are currently focused on
understanding the molecular
basis for the development of
B cell chronic lymphocytic
leukemia (CLL). More broadly,
he is interested in B cell
biology, particularly B cell
maturation and development
and its relationship to disease
and autoimmunity.
Dr. Davidson are focused on
pathogenesis and therapy of
lupus. Her lab's first goal is to
understand more about the
regulation of autoantibody-
producing B cells and to use
newly-discovered pathways of
immune activation to design
and test novel therapies
for lupus.
research is to improve the
understanding of Alzheimer's
disease to allow for the
discovery, development and
testing of effective therapies.
Recent work focuses on
activation of cell cycle
mechanisms in Alzheimer's
disease and modifications of
the microtubule associated
protein tau as a reporter for
signal transduction in the
human brain.